[22] showed that IL-17A enhances migration and invasiveness of GC cells via activation of NF-kB pathway and subsequent upregulation of MMP-2 and MMP-9, consistent with earlier reports that GC cells or tumor-associated neutrophils produce IL-17A, which is associated with EMT [20, 21]. The gene discussed is MMP9; the disease is gastric cancer.